OPHTHALMOLOGY

Dry eye disease,
a well-known “civilisation disease”

20 years ago, our hyaluronic acid-based lubricant eye drops meet high compliance and patient satisfaction.

Affecting between 5% and 34% of people worldwide, Dry eye disease represents a significant economic burden due to direct and indirect healthcare costs such as reduced work productivity.1,2,3 We have developed the VISMED® (range of lubricant eye drops consisting of hypo-osmolar sodium hyaluronate solutions) to treat symptoms and signs of dry eye, ocular surface damage and eye irritation due to different diseases such as superficial keratitis, Sjögren’s syndrome, or primary dry eye syndrome.4-6 The VISMED® product range has been formulated in order to break the vicious cycle of dry eye by counteracting tear hyperosmolarity and stabilising the tear film.7 With a choice of sodium hyaluronate concentrations varying from 0.1% to 0.3%, we offer an adaptable range of concentrations to meet the patient’s specific needs.

Find out more about our products for dry eye and eye surgery

Learn more